Cargando…
Novel Dual-Targeting Antibody Fragment IDB0062 Overcomes Anti–Vascular Endothelial Growth Factor Drug Limitations in Age-Related Macular Degeneration
PURPOSE: Repeated administration of anti–vascular endothelial growth factor drugs to treat age-related macular degeneration leads to resistance. To overcome this drawback, we developed the novel recombinant dual-targeting antibody fragment IDB0062, which is comprised of the anti–vascular endothelial...
Autores principales: | Kim, Seongbeom, Min, Gihong, Kim, Bomin, Lee, Doseop, Lee, Myongjae, Ko, Jong-Hee, Kwon, Hyuk-Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727311/ https://www.ncbi.nlm.nih.gov/pubmed/34967833 http://dx.doi.org/10.1167/tvst.10.14.35 |
Ejemplares similares
-
Preclinical Efficacy and Safety of an Anti-Human VEGFA and Anti-Human NRP1 Dual-Targeting Bispecific Antibody (IDB0076)
por: Ko, Jong-Hee, et al.
Publicado: (2020) -
An Identity-Based (IDB) Broadcast Encryption Scheme with Personalized Messages (BEPM)
por: Xu, Ke, et al.
Publicado: (2015) -
Data collection and analysis on the burden of injuries: Lessons learned from the IDB network
por: Bauer, R, et al.
Publicado: (2023) -
Arena-Idb: a platform to build human non-coding RNA interaction networks
por: Bonnici, Vincenzo, et al.
Publicado: (2018) -
PlantMWpIDB: a database for the molecular weight and isoelectric points of the plant proteomes
por: Mohanta, Tapan Kumar, et al.
Publicado: (2022)